Remicade infliximab anti-TNF chimeric monoclonal antibody regulatory update

JNJ's Centocor Inc. subsidiary (Malvern, Penn.) said it is revising the label for Remicade

Read the full 149 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE